NCT01300286View on ClinicalTrials.gov

Open Label Use Of RiaStap During Aortic Reconstruction

PHASE4CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Coagulopathic Bleeding

Interventions

DRUG

RiaSTAP

One time dose of 70 mg/kg will be administered intravenously.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

All Listed Sponsors

collaborator

CSL Behring

INDUSTRY

lead

Duke University

OTHER